FOXM1’s interaction with NIMA-related kinase 2 (NEK2) and the CDK4/6-Rb-E2F axis, in myeloma cells, is considered to be useful from a therapeutic aspect, because CDK inhibition is thought to be effective in myeloma treatment [156,157,158,159]. The gene discussed is NEK2; the disease is plasma cell myeloma.